DAILIPORT

This brand name is authorized in Austria, Estonia, Finland, Lithuania, Netherlands, Poland, Turkey, UK.

Active ingredients

The drug DAILIPORT contains one active pharmaceutical ingredient (API):

1	Tacrolimus monohydrate UNII WM0HAQ4WNM - TACROLIMUS
	Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.
	Read more about Tacrolimus

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DAILIPORT Prolonged-release hard capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AD02	Tacrolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1776607, 1776618, 1776629, 1776630, 1776641, 1776652, 1776663, 1776674, 1776685, 1776696, 1776708, 1776719, 1776720, 1776731, 1776742, 1776753, 1776764, 1776775, 1776786, 1776797
FI	Lääkealan turvallisuus- ja kehittämiskeskus	044310, 073881, 159369, 434757, 492253
GB	Medicines & Healthcare Products Regulatory Agency	379398, 379400, 379401, 379403, 379405, 379412
LT	Valstybinė vaistų kontrolės tarnyba	1088730, 1088731, 1088732, 1088733, 1088734, 1088735, 1088736, 1088737, 1088738, 1088739, 1088740, 1088741, 1088742, 1088743, 1088744, 1088745, 1088746, 1088747, 1088748, 1088749, 1088750, 1088751, 1088752, 1088753, 1088754, 1088755, 1088756, 1088757, 1088758, 1088759, 1088760, 1088761, 1088762, 1088763, 1088764, 1088765, 1088766, 1088767, 1088768, 1088769
NL	Z-Index G-Standaard, PRK	200719, 96148, 96156, 96164, 96172
PL	Rejestru Produktów Leczniczych	100409795, 100409803, 100409810, 100409826, 100409832
TR	İlaç ve Tıbbi Cihaz Kurumu	8681428171538, 8681428171545, 8681428171552, 8681428171569, 8681428171576, 8681428171583, 8681428171590, 8681428171606, 8681428171613, 8681428171620, 8681428171637, 8681428171644, 8681428171651, 8681428171668, 8681428171675